Tag Archive for: drug repurposing
Taiwanese Study Uncovers Cancer-Fighting Potential of Common Allergy Drug
/0 Comments/in Drug repurposing, Preclinical Research/by MaxPioglitazone: Diabetes Drug Shows Promise for Treating Prostate Cancer
/0 Comments/in Drug repurposing, Preclinical Research/by MaxOvercoming Resistance in Metastatic Prostate Cancer: Repurposing Pimitespib
/0 Comments/in Drug repurposing, Preclinical Research/by MaxPredictive Oncology’s Breakthrough in Drug Repurposing Offers Hope for Patients
/0 Comments/in Drug repurposing, Preclinical Research/by MaxAI-Powered Drug Repurposing Advances: Using Artificial Intelligence to Find New Cancer Treatments
/0 Comments/in Artificial Intelligence/by MaxRepurposing Non-Cancer Drugs: A New Frontier in Personalized Oncology
/0 Comments/in Artificial Intelligence, Preclinical Research/by MaxProject Navigator
Let's try to finance it!
A new, user friendly way, to get information about current clinical trials available to prostate cancer patients.
Tags
225Ac abiraterone acetate ADC AI ai in healthcare alphafold antibody-drug conjugate apalutamide ASCO 2025 ATM bispecific antibody bone metastases bone metastasis BRCA cancer immunotherapy CAR-T clinical trial clinical trials crispr CYP11A1 inhibitor darolutamide drug repurposing drug resistance enzalutamide HRR immunotherapy mcrpc metastatic castration-resistant prostate cancer metastatic hormone-sensitive prostate cancer mHSPC mRNA NEPC neuroendocrine prostate cancer olaparib oncolytic virus PARP inhibitor Pluvicto prostate cancer protac PSMA radioligand therapy radiopharmaceuticals real-world data STAMPEDE trial theranostics
Latest Posts
- Memantine Shows Promise Against Advanced Prostate Cancer September 11, 2025
- Pasritamig in Late-Line Prostate Cancer: From Early Findings to the KLK2-comPAS Trial September 11, 2025
- FDA Clears First Therapeutic Trial of Lead-212 Radioligand AB001 in Prostate Cancer September 11, 2025
- How Eating Patterns Shape Prostate Cancer Outcomes: A Global Review September 9, 2025